Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daren Fearon

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Bioorganic & Medicinal Chemistry|May 17, 2018
Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibitionDaren Fearon, Isaac M Westwood, Rob L M van Montfort, et al.
Organic Letters|October 20, 2022
Synthesis of a Thiazole Library via an Iridium-Catalyzed Sulfur Ylide Insertion ReactionStorm Hassell-Hart, Elisa Speranzini, Sirihathai Srikwanjai, et al.
Chemmedchem|May 23, 2026
Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking ApproachesLevente Kollár, Levente M Mihalovits, Dávid Bajusz, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
How many crystal structures do you need to trust your docking results?Alexander Matthew Payne, Benjamin Kaminow, Hugo MacDermott-Opeskin, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain InhibitorsMarion Schuller, Tryfon Zarganes-Tzitzikas, James Bennett, et al.
Nature Communications|May 5, 2025
Where and how to house big data on small fragmentsDaniel A Erlanson, Stephen K Burley, Daren Fearon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
Turning high-throughput structural biology into predictive inhibitor designKadi L Saar, William McCorkindale, Daren Fearon, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflaviviralsManisha Saini, Jasmin C Aschenbrenner, Francesc Xavier Ruiz, et al.
Journal of Medicinal Chemistry|September 2, 2025
Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside AntiflaviviralsManisha Saini, Jasmin C Aschenbrenner, Francesc Xavier Ruiz, et al.
RSC Chemical Biology|August 17, 2022
Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitorsEvgenii M Osipov, Ali H Munawar, Steven Beelen, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|May 17, 2018
Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibitionDaren Fearon, Isaac M Westwood, Rob L M van Montfort, et al.
Organic Letters|October 20, 2022
Synthesis of a Thiazole Library via an Iridium-Catalyzed Sulfur Ylide Insertion ReactionStorm Hassell-Hart, Elisa Speranzini, Sirihathai Srikwanjai, et al.
Chemmedchem|May 23, 2026
Fragment-Based Design of Targeted Covalent Inhibitors: The Scope and Limitation of Linking ApproachesLevente Kollár, Levente M Mihalovits, Dávid Bajusz, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
How many crystal structures do you need to trust your docking results?Alexander Matthew Payne, Benjamin Kaminow, Hugo MacDermott-Opeskin, et al.
Pathogens (Basel, Switzerland)|February 25, 2023
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain InhibitorsMarion Schuller, Tryfon Zarganes-Tzitzikas, James Bennett, et al.
Nature Communications|May 5, 2025
Where and how to house big data on small fragmentsDaniel A Erlanson, Stephen K Burley, Daren Fearon, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2023
Turning high-throughput structural biology into predictive inhibitor designKadi L Saar, William McCorkindale, Daren Fearon, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflaviviralsManisha Saini, Jasmin C Aschenbrenner, Francesc Xavier Ruiz, et al.
Journal of Medicinal Chemistry|September 2, 2025
Crystallographic Fragment Screening of the Dengue Virus Polymerase Reveals Multiple Binding Sites for the Development of Non-nucleoside AntiflaviviralsManisha Saini, Jasmin C Aschenbrenner, Francesc Xavier Ruiz, et al.
RSC Chemical Biology|August 17, 2022
Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitorsEvgenii M Osipov, Ali H Munawar, Steven Beelen, et al.
Pageof 5